

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.53701630 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85830842 |
| 3 | positive regulation of granulocyte differentiation (GO:0030854) | 4.66863659 |
| 4 | negative T cell selection (GO:0043383) | 4.25838147 |
| 5 | negative thymic T cell selection (GO:0045060) | 4.16415976 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.08219782 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08219782 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07830515 |
| 9 | B cell receptor signaling pathway (GO:0050853) | 4.06643928 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04424249 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.01783425 |
| 12 | T cell migration (GO:0072678) | 4.01021027 |
| 13 | negative regulation of T cell mediated immunity (GO:0002710) | 3.95910059 |
| 14 | cellular extravasation (GO:0045123) | 3.89810078 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 3.79573316 |
| 16 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.76326676 |
| 17 | positive T cell selection (GO:0043368) | 3.63474274 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.61400540 |
| 19 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.57541332 |
| 20 | response to muramyl dipeptide (GO:0032495) | 3.54845969 |
| 21 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.53210401 |
| 22 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.51276503 |
| 23 | response to peptidoglycan (GO:0032494) | 3.49706351 |
| 24 | hepatocyte apoptotic process (GO:0097284) | 3.47761267 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.42699211 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41774026 |
| 27 | regulation of B cell differentiation (GO:0045577) | 3.39083140 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.36223052 |
| 29 | neutrophil mediated immunity (GO:0002446) | 3.33626998 |
| 30 | regulation of granulocyte differentiation (GO:0030852) | 3.33427126 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.32169832 |
| 32 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.23442859 |
| 33 | T-helper cell differentiation (GO:0042093) | 3.23442859 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.23182218 |
| 35 | T cell selection (GO:0045058) | 3.21417017 |
| 36 | detection of other organism (GO:0098543) | 3.20388110 |
| 37 | positive thymic T cell selection (GO:0045059) | 3.18339104 |
| 38 | definitive hemopoiesis (GO:0060216) | 3.16729952 |
| 39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.16050947 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.16050947 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 3.16050947 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.16050947 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.16050947 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.16050947 |
| 45 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.13258787 |
| 46 | detection of bacterium (GO:0016045) | 3.07540545 |
| 47 | interferon-gamma production (GO:0032609) | 3.07374485 |
| 48 | dosage compensation (GO:0007549) | 3.06954487 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06283386 |
| 50 | B cell homeostasis (GO:0001782) | 3.05842569 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02495076 |
| 52 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.01687080 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.01687080 |
| 54 | NIK/NF-kappaB signaling (GO:0038061) | 2.94750722 |
| 55 | myeloid leukocyte mediated immunity (GO:0002444) | 2.94616551 |
| 56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.94603746 |
| 57 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.93181963 |
| 58 | histone H3-K36 demethylation (GO:0070544) | 2.92243279 |
| 59 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.92036917 |
| 60 | histone H3-K4 trimethylation (GO:0080182) | 2.91581688 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.89097849 |
| 62 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.88983862 |
| 63 | tolerance induction (GO:0002507) | 2.88973837 |
| 64 | cellular response to ethanol (GO:0071361) | 2.88186193 |
| 65 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87690142 |
| 66 | positive regulation of interferon-beta production (GO:0032728) | 2.84730325 |
| 67 | B cell proliferation (GO:0042100) | 2.83652761 |
| 68 | alpha-beta T cell activation (GO:0046631) | 2.82699844 |
| 69 | positive regulation of interleukin-2 production (GO:0032743) | 2.82635906 |
| 70 | microglial cell activation (GO:0001774) | 2.81434753 |
| 71 | protein K11-linked deubiquitination (GO:0035871) | 2.81390673 |
| 72 | T cell homeostasis (GO:0043029) | 2.81361085 |
| 73 | regulation of germinal center formation (GO:0002634) | 2.80954927 |
| 74 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.79672083 |
| 75 | mature B cell differentiation (GO:0002335) | 2.77230612 |
| 76 | mast cell activation (GO:0045576) | 2.74385929 |
| 77 | T cell differentiation involved in immune response (GO:0002292) | 2.73347947 |
| 78 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.73347947 |
| 79 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.73347947 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 2.73008740 |
| 81 | alpha-beta T cell differentiation (GO:0046632) | 2.72577402 |
| 82 | positive regulation of B cell activation (GO:0050871) | 2.72278295 |
| 83 | leukocyte aggregation (GO:0070486) | 2.71727226 |
| 84 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.70970141 |
| 85 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.70800793 |
| 86 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.70691772 |
| 87 | thymic T cell selection (GO:0045061) | 2.69812179 |
| 88 | T cell proliferation (GO:0042098) | 2.67060547 |
| 89 | positive regulation of interferon-alpha production (GO:0032727) | 2.66222543 |
| 90 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66218251 |
| 91 | response to host immune response (GO:0052572) | 2.66218251 |
| 92 | negative regulation of adaptive immune response (GO:0002820) | 2.64964600 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 2.64264545 |
| 94 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.63568467 |
| 95 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.63019073 |
| 96 | response to interleukin-15 (GO:0070672) | 2.61786260 |
| 97 | detection of external biotic stimulus (GO:0098581) | 2.60903940 |
| 98 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.60525533 |
| 99 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.60525533 |
| 100 | regulation of B cell proliferation (GO:0030888) | 2.60033329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.42247551 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.05522166 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.14354929 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.64980480 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.07459711 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.06097422 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.04255671 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.95458605 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.82030761 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80096181 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.74935524 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59410050 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50684397 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44074467 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38640713 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37057630 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33083626 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.28641003 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26675086 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.25116938 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23407258 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.08996411 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99072652 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96899343 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96086524 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.96083681 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.95281823 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82404725 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81000661 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77250516 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75171257 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.69268914 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68452434 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67085355 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.66215034 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.66182716 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.64377994 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63802983 |
| 39 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.62862528 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61131566 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.55334435 |
| 42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.47762303 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42731670 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41280440 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40430911 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.38137817 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35483247 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34172699 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.31268178 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29213324 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28702174 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27256647 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.24402294 |
| 54 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23397715 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17789290 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17764440 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17585470 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15122393 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13518717 |
| 60 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11667292 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07474285 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06299174 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.05762843 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05300510 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03650097 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03636372 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01261479 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00723295 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00049903 |
| 70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97643561 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97091779 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94747358 |
| 73 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94532263 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93595059 |
| 75 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93112343 |
| 76 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92835944 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91517438 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91407480 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91103229 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89580790 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89028322 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88843143 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86965204 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86853562 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86727134 |
| 86 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.86378744 |
| 87 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86148624 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85223230 |
| 89 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.84957721 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84899077 |
| 91 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84899077 |
| 92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83865704 |
| 93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83551521 |
| 94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.82432294 |
| 95 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82404190 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81320998 |
| 97 | EWS_26573619_Chip-Seq_HEK293_Human | 0.79918732 |
| 98 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.79794601 |
| 99 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.78861591 |
| 100 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75314808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 3.70820876 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.47542784 |
| 3 | MP0008057_abnormal_DNA_replication | 3.36129449 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.20552516 |
| 5 | MP0001800_abnormal_humoral_immune | 2.75326315 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.73365488 |
| 7 | MP0005671_abnormal_response_to | 2.63908694 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.62939086 |
| 9 | MP0003436_decreased_susceptibility_to | 2.49857285 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.45412948 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.42369794 |
| 12 | MP0000685_abnormal_immune_system | 2.41552898 |
| 13 | MP0005387_immune_system_phenotype | 2.28551599 |
| 14 | MP0001790_abnormal_immune_system | 2.28551599 |
| 15 | MP0002723_abnormal_immune_serum | 2.27255711 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.26524411 |
| 17 | MP0003724_increased_susceptibility_to | 2.20512523 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.20383757 |
| 19 | MP0001819_abnormal_immune_cell | 2.16656787 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.11670928 |
| 21 | MP0002006_tumorigenesis | 2.09360591 |
| 22 | MP0002398_abnormal_bone_marrow | 2.06637825 |
| 23 | MP0002419_abnormal_innate_immunity | 2.03605350 |
| 24 | MP0003303_peritoneal_inflammation | 2.03217981 |
| 25 | MP0009785_altered_susceptibility_to | 2.02532725 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.96842437 |
| 27 | MP0002405_respiratory_system_inflammati | 1.93300565 |
| 28 | MP0006082_CNS_inflammation | 1.93176114 |
| 29 | MP0005025_abnormal_response_to | 1.90428144 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.82418374 |
| 31 | MP0000716_abnormal_immune_system | 1.82250971 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.80706990 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.74831406 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.70565891 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.70565891 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.70398878 |
| 37 | MP0001873_stomach_inflammation | 1.67738391 |
| 38 | MP0003828_pulmonary_edema | 1.66912553 |
| 39 | MP0004947_skin_inflammation | 1.66007318 |
| 40 | MP0002722_abnormal_immune_system | 1.65716120 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.62764008 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.60942042 |
| 43 | MP0005310_abnormal_salivary_gland | 1.60596327 |
| 44 | MP0001853_heart_inflammation | 1.56840192 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.52793386 |
| 46 | MP0002429_abnormal_blood_cell | 1.45913694 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.45703500 |
| 48 | MP0001851_eye_inflammation | 1.45120930 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.44656998 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.42074299 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.38635347 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.33286007 |
| 53 | MP0004381_abnormal_hair_follicle | 1.27923388 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.13838494 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.11680898 |
| 56 | MP0009278_abnormal_bone_marrow | 1.10846764 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.10828275 |
| 58 | MP0004883_abnormal_blood_vessel | 1.08537667 |
| 59 | MP0008995_early_reproductive_senescence | 1.08360899 |
| 60 | MP0003866_abnormal_defecation | 1.07069580 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.06837244 |
| 62 | MP0009764_decreased_sensitivity_to | 1.05183483 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.03843830 |
| 64 | MP0008469_abnormal_protein_level | 1.02330438 |
| 65 | MP0002095_abnormal_skin_pigmentation | 0.93207471 |
| 66 | MP0003252_abnormal_bile_duct | 0.93039808 |
| 67 | MP0002163_abnormal_gland_morphology | 0.92601742 |
| 68 | MP0003091_abnormal_cell_migration | 0.91773280 |
| 69 | MP0005164_abnormal_response_to | 0.91636175 |
| 70 | MP0003786_premature_aging | 0.90765485 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.89204001 |
| 72 | MP0003172_abnormal_lysosome_physiology | 0.88122023 |
| 73 | MP0002928_abnormal_bile_duct | 0.88054360 |
| 74 | MP0002019_abnormal_tumor_incidence | 0.87449511 |
| 75 | MP0009115_abnormal_fat_cell | 0.86131456 |
| 76 | MP0002332_abnormal_exercise_endurance | 0.86039458 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 0.80562484 |
| 78 | MP0000858_altered_metastatic_potential | 0.80189439 |
| 79 | MP0001533_abnormal_skeleton_physiology | 0.78693770 |
| 80 | MP0009763_increased_sensitivity_to | 0.76855135 |
| 81 | MP0002132_abnormal_respiratory_system | 0.76788407 |
| 82 | MP0003045_fibrosis | 0.75999590 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.73786892 |
| 84 | MP0002998_abnormal_bone_remodeling | 0.71653438 |
| 85 | MP0008004_abnormal_stomach_pH | 0.70830768 |
| 86 | MP0008260_abnormal_autophagy | 0.69687062 |
| 87 | MP0001191_abnormal_skin_condition | 0.69605387 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.68962118 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.67298703 |
| 90 | MP0005451_abnormal_body_composition | 0.66779778 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.66389315 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.65383449 |
| 93 | MP0000609_abnormal_liver_physiology | 0.65353214 |
| 94 | MP0005266_abnormal_metabolism | 0.64764631 |
| 95 | MP0004484_altered_response_of | 0.62894908 |
| 96 | MP0000427_abnormal_hair_cycle | 0.62692066 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.62440662 |
| 98 | MP0000372_irregular_coat_pigmentation | 0.62197910 |
| 99 | MP0005621_abnormal_cell_physiology | 0.62065932 |
| 100 | MP0001919_abnormal_reproductive_system | 0.61797201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.10097439 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.96931750 |
| 3 | Recurrent viral infections (HP:0004429) | 3.93203014 |
| 4 | Abnormality of T cell number (HP:0011839) | 3.91580791 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 3.89329402 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.76768905 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76047925 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.64572029 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.59268906 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 3.58790572 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50907775 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50907775 |
| 13 | Stomatitis (HP:0010280) | 3.49586389 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.38747192 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 3.31871887 |
| 16 | Abnormality of B cell number (HP:0010975) | 3.28457863 |
| 17 | Abnormality of T cells (HP:0002843) | 3.24838230 |
| 18 | B lymphocytopenia (HP:0010976) | 3.17399391 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.14463161 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.10606704 |
| 21 | Colitis (HP:0002583) | 3.07690174 |
| 22 | Myositis (HP:0100614) | 3.03931671 |
| 23 | Meningitis (HP:0001287) | 2.98529967 |
| 24 | Papilledema (HP:0001085) | 2.94528905 |
| 25 | Recurrent bronchitis (HP:0002837) | 2.94036007 |
| 26 | Recurrent skin infections (HP:0001581) | 2.93303929 |
| 27 | Fatigue (HP:0012378) | 2.92917616 |
| 28 | Granulocytopenia (HP:0001913) | 2.92141891 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.91999033 |
| 30 | Optic neuritis (HP:0100653) | 2.91999033 |
| 31 | Thyroiditis (HP:0100646) | 2.91665100 |
| 32 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.90503846 |
| 33 | Vasculitis (HP:0002633) | 2.89227591 |
| 34 | Keratoconjunctivitis (HP:0001096) | 2.86320335 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.84774038 |
| 36 | Eosinophilia (HP:0001880) | 2.78466258 |
| 37 | Acute myeloid leukemia (HP:0004808) | 2.78424509 |
| 38 | Increased IgE level (HP:0003212) | 2.76610954 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.72631526 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.72045678 |
| 41 | Pustule (HP:0200039) | 2.71709116 |
| 42 | Papilloma (HP:0012740) | 2.68442509 |
| 43 | Verrucae (HP:0200043) | 2.68442509 |
| 44 | Papillary thyroid carcinoma (HP:0002895) | 2.65332231 |
| 45 | Orchitis (HP:0100796) | 2.64913686 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.63935049 |
| 47 | Hypoplasia of the thymus (HP:0000778) | 2.63929049 |
| 48 | Encephalitis (HP:0002383) | 2.60757402 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.59746338 |
| 50 | Viral hepatitis (HP:0006562) | 2.59654709 |
| 51 | Combined immunodeficiency (HP:0005387) | 2.54338300 |
| 52 | Osteomyelitis (HP:0002754) | 2.50351256 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.49500037 |
| 54 | Metaphyseal dysplasia (HP:0100255) | 2.48583127 |
| 55 | Leukocytosis (HP:0001974) | 2.47872841 |
| 56 | Abnormality of macrophages (HP:0004311) | 2.45405058 |
| 57 | Cellulitis (HP:0100658) | 2.42934283 |
| 58 | Chronic diarrhea (HP:0002028) | 2.42443597 |
| 59 | Menstrual irregularities (HP:0000858) | 2.41057896 |
| 60 | Basal cell carcinoma (HP:0002671) | 2.31161886 |
| 61 | Anhidrosis (HP:0000970) | 2.28343482 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.28104363 |
| 63 | Lymphopenia (HP:0001888) | 2.27783531 |
| 64 | Hematochezia (HP:0002573) | 2.26202430 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.23655171 |
| 66 | Stomach cancer (HP:0012126) | 2.21316102 |
| 67 | IgM deficiency (HP:0002850) | 2.20510051 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.16774971 |
| 69 | Keratitis (HP:0000491) | 2.15316972 |
| 70 | IgG deficiency (HP:0004315) | 2.14709885 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.08059938 |
| 72 | Slow saccadic eye movements (HP:0000514) | 2.05362357 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05308855 |
| 74 | Syringomyelia (HP:0003396) | 2.03085215 |
| 75 | Spinal cord lesions (HP:0100561) | 2.03085215 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 1.99534869 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 1.98156750 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97572755 |
| 79 | Thyroid carcinoma (HP:0002890) | 1.96689809 |
| 80 | Gingivitis (HP:0000230) | 1.96016876 |
| 81 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.95267566 |
| 82 | Sepsis (HP:0100806) | 1.94223815 |
| 83 | Urticaria (HP:0001025) | 1.90665971 |
| 84 | Prominent nose (HP:0000448) | 1.90289886 |
| 85 | Abnormality of the fingertips (HP:0001211) | 1.89780755 |
| 86 | Gingival bleeding (HP:0000225) | 1.88871599 |
| 87 | Subacute progressive viral hepatitis (HP:0006572) | 1.88194913 |
| 88 | Dry hair (HP:0011359) | 1.86513345 |
| 89 | Epistaxis (HP:0000421) | 1.84700353 |
| 90 | Lymphoma (HP:0002665) | 1.84465218 |
| 91 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.82928279 |
| 92 | Fair hair (HP:0002286) | 1.82909627 |
| 93 | Gangrene (HP:0100758) | 1.82081693 |
| 94 | Chest pain (HP:0100749) | 1.81650099 |
| 95 | Exocrine pancreatic insufficiency (HP:0001738) | 1.81486146 |
| 96 | Recurrent sinusitis (HP:0011108) | 1.79184660 |
| 97 | Increased CSF protein (HP:0002922) | 1.78665859 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77775994 |
| 99 | Obstructive lung disease (HP:0006536) | 1.77775994 |
| 100 | Hemoptysis (HP:0002105) | 1.75093865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.15258537 |
| 2 | MAP3K14 | 2.69929681 |
| 3 | BMPR2 | 2.67916935 |
| 4 | RIPK4 | 2.56005286 |
| 5 | IKBKE | 2.54183571 |
| 6 | MAP4K1 | 2.50005883 |
| 7 | PRPF4B | 2.32294467 |
| 8 | IRAK4 | 2.27653497 |
| 9 | FRK | 2.17192877 |
| 10 | BTK | 2.03555840 |
| 11 | SCYL2 | 2.03094501 |
| 12 | TYK2 | 1.95441622 |
| 13 | TEC | 1.95354468 |
| 14 | JAK1 | 1.93041074 |
| 15 | PIK3CG | 1.85907170 |
| 16 | BRD4 | 1.84951083 |
| 17 | BLK | 1.83622733 |
| 18 | TXK | 1.82218916 |
| 19 | NEK9 | 1.80908459 |
| 20 | SIK3 | 1.75632573 |
| 21 | EIF2AK3 | 1.69499415 |
| 22 | ITK | 1.69022557 |
| 23 | SYK | 1.65235945 |
| 24 | NLK | 1.64314215 |
| 25 | CDK12 | 1.59439209 |
| 26 | FGFR3 | 1.53256578 |
| 27 | IKBKB | 1.53034426 |
| 28 | IRAK1 | 1.49149209 |
| 29 | MAP3K2 | 1.42112905 |
| 30 | AKT3 | 1.40664228 |
| 31 | TBK1 | 1.36361112 |
| 32 | GRK6 | 1.35993159 |
| 33 | CAMKK2 | 1.35211757 |
| 34 | ERBB3 | 1.34576347 |
| 35 | MARK3 | 1.31949814 |
| 36 | PASK | 1.29052958 |
| 37 | MST4 | 1.27873955 |
| 38 | JAK3 | 1.25970039 |
| 39 | CSK | 1.24693604 |
| 40 | MAP3K13 | 1.21968332 |
| 41 | TRPM7 | 1.18384392 |
| 42 | KIT | 1.16473238 |
| 43 | HCK | 1.16230272 |
| 44 | PIM1 | 1.16127630 |
| 45 | MAP2K3 | 1.14281542 |
| 46 | ZAP70 | 1.13834065 |
| 47 | LCK | 1.10906345 |
| 48 | STK10 | 1.10866076 |
| 49 | LYN | 1.08834202 |
| 50 | JAK2 | 1.07253052 |
| 51 | MAP3K12 | 1.06528173 |
| 52 | YES1 | 1.06244238 |
| 53 | CDK6 | 1.05677399 |
| 54 | FES | 1.00191794 |
| 55 | MAPK7 | 0.97466410 |
| 56 | MAP3K10 | 0.93549245 |
| 57 | MAP3K5 | 0.92195986 |
| 58 | IRAK2 | 0.91795470 |
| 59 | MAP3K1 | 0.83540271 |
| 60 | KSR1 | 0.81257177 |
| 61 | CHUK | 0.80199956 |
| 62 | HIPK2 | 0.79207346 |
| 63 | PRKCQ | 0.77753787 |
| 64 | MAPK11 | 0.76573694 |
| 65 | MAP3K6 | 0.73529501 |
| 66 | STK24 | 0.73041605 |
| 67 | WNK1 | 0.72789423 |
| 68 | SGK2 | 0.68830152 |
| 69 | DYRK1B | 0.68675297 |
| 70 | IRAK3 | 0.68137466 |
| 71 | CSF1R | 0.67258398 |
| 72 | EPHA3 | 0.66959485 |
| 73 | CLK1 | 0.65505898 |
| 74 | MAP3K3 | 0.65424624 |
| 75 | PDK1 | 0.62516086 |
| 76 | MELK | 0.59216909 |
| 77 | MAPK12 | 0.56624538 |
| 78 | PIK3CA | 0.53670505 |
| 79 | MAP4K2 | 0.53479095 |
| 80 | ABL1 | 0.51712778 |
| 81 | RAF1 | 0.51286585 |
| 82 | STK3 | 0.50496196 |
| 83 | TNK2 | 0.49665094 |
| 84 | CDK4 | 0.49155532 |
| 85 | GRK7 | 0.49017613 |
| 86 | RPS6KA4 | 0.47035258 |
| 87 | SIK2 | 0.43699209 |
| 88 | SGK3 | 0.43695727 |
| 89 | NEK6 | 0.39689603 |
| 90 | MARK2 | 0.39303175 |
| 91 | CCNB1 | 0.37551476 |
| 92 | ACVR1B | 0.37204180 |
| 93 | TRIM28 | 0.36245327 |
| 94 | EGFR | 0.29801351 |
| 95 | DYRK3 | 0.29765325 |
| 96 | MAP3K4 | 0.29089448 |
| 97 | MAPK3 | 0.28624145 |
| 98 | RPS6KA5 | 0.28551212 |
| 99 | RET | 0.28102768 |
| 100 | KSR2 | 0.26696406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.90454415 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.74862230 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32962896 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.31558302 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25653269 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20347398 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.15868339 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14310195 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13553076 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10551475 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.09479236 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.09110101 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.07140023 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.01095166 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91661168 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.90640830 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.82852936 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.78464708 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71981283 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67159694 |
| 21 | Hepatitis B_Homo sapiens_hsa05161 | 1.66836434 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63771859 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.62158605 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.59053346 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.58940388 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.57856371 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54037699 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.47978519 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.47844202 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40512420 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.33632820 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.30163995 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29377034 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21131261 |
| 35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.17816091 |
| 36 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16503732 |
| 37 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.15612867 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15056768 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14714230 |
| 40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.13041728 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.11952734 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.06755508 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05135099 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05028345 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05026941 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.03882093 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.02132671 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00883218 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00654727 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 1.00303439 |
| 51 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00250902 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93849462 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93736378 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93656033 |
| 55 | Prostate cancer_Homo sapiens_hsa05215 | 0.93296032 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92361596 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92232198 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89236802 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88413011 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87946111 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.83309213 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82883136 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80894809 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.80179358 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76890093 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75319173 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72208348 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71916116 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69011736 |
| 70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68445547 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.66239157 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66177655 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.66092832 |
| 74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.65762639 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64588345 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63586532 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61895399 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61792966 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58680613 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58221920 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58154620 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.57390572 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55079963 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53602401 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51507476 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51291603 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.50047199 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48540123 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48136617 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47267633 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46338312 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42717965 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41678573 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39586534 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.37530178 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37163983 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.36788611 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.36188465 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35945337 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33454079 |

